Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggressive disease phenotype
- 22 June 2022
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 43 (10) , 6087-6090
Abstract
Background ALS symptoms have been previously described only in the context of ATXN2 CAG expansions, whereas missense mutations of the gene have never been described in ALS patients. Case presentation We identified a novel missense mutation (c.2860C > T) of ATXN2, for which in silico analysis showed a possible pathogenic effect on protein expression, in a patient presenting an aggressive disease phenotype. Discussion Our findings raise the possibility for unknown genetic factors interacting with ATXN2 mutations, or for an autonomous pathogenic role for this specific point mutation in ATXN2 gene in driving the clinical phenotype toward ALS. We also found that stress granules in the fibroblasts from the patient entrapped higher amounts of defective ribosomal products compared to fibroblasts from three healthy subjects, suggesting that ATXN2 mutation-related toxicity may have implication in protein quality control.Keywords
Funding Information
- Agenzia Italiana del Farmaco, Ministero della Salute (2016-02364678)
- Fondazione Cassa di Risparmio di Modena
This publication has 10 references indexed in Scilit:
- Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's diseaseNeurobiology of Aging, 2020
- Ataxin-2: From RNA Control to Human Health and DiseaseGenes, 2017
- Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 miceNature, 2017
- A Surveillance Function of the HSPB8-BAG3-HSP70 Chaperone Complex Ensures Stress Granule Integrity and DynamismMolecular Cell, 2016
- Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin‐2 to induce motor neuron dysfunction and cell deathThe EMBO Journal, 2016
- Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disordersNeurology, 2014
- Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosisHuman Molecular Genetics, 2012
- The FTD/ALS-associated RNA-binding protein TDP-43 regulates the robustness of neuronal specification through microRNA-9a in DrosophilaHuman Molecular Genetics, 2012
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSNature, 2010
- Ataxin-2 Interacts with the DEAD/H-Box RNA Helicase DDX6 and Interferes with P-Bodies and Stress GranulesMolecular Biology of the Cell, 2007